[Federal Register Volume 86, Number 63 (Monday, April 5, 2021)]
[Notices]
[Page 17642]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06900]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-810]


Importer of Controlled Substances Application: Royal Emerald 
Pharmaceuticals Research and Development DBA: Royal Emerald 
Pharmaceuticals

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Royal Emerald Pharmaceuticals Research and Development DBA: 
Royal Emerald Pharmaceuticals has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before May 5, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before May 5, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on May 22, 2020, Royal Emerald Pharmaceuticals Research 
and Development DBA: Royal Emerald Pharmaceuticals, 14011 Palm Drive, 
Desert Hot Springs, California 92240, applied to be registered as an 
importer of the following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Marihuana..............................    7360  I
Tetrahydrocannabinols..................    7370  I
------------------------------------------------------------------------

    The company plans to import Marihuana seeds and immature Marihuana 
plants in the form of Active Pharmaceutical Ingredients (API) and 
botanical raw materials for DEA-approved legitimate scientific medical 
research and/or industrial purposes.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-06900 Filed 4-2-21; 8:45 am]
BILLING CODE P